Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.69 |
| ▸ | RAB9A | P51151 | 8/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.69 |
| ▸ | MEN1 | O00255 | 7/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.69 |
| ▸ | NPC1 | O15118 | 6/20 | 0.69 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.67 |
| ▸ | GAA | P10253 | 8/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.62 |
| ▸ | RELA | Q04206 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | CRHBP | P24387 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11388177 | 0.85 | NOX1 (0.91) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL11388174 | 0.85 | NOX1 (0.91) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL1164826 | 0.83 | MAPT (0.63) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL1164827 | 0.83 | MAPT (0.63) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL7863736 | 0.83 | MAPT (0.68) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL7863738 | 0.83 | MAPT (0.68) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL14839363 | 0.81 | RAB9A (0.64) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL22874080 | 0.81 | NOX1 (1.00) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL42160 | 0.81 | NOX1 (1.00) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL42159 | 0.81 | NOX1 (1.00) | MAPTRAB9AKMT2AMEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260009142-A1 | Electrochemical synthesis of pyrazolines and pyrazoles | BAYER AG (DE) | 2026-01-08 | — | — | US | disclosed |
| CN-119698496-A | Electrochemical synthesis of pyrazolines and pyrazoles | 拜耳公司 | 2025-03-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009142-A1 | Electrochemical synthesis of pyrazolines and pyrazoles | CYP2E1, CYP2F1, CYP4F2 | MAPT 4836/4885RAB9A 4644/4885KMT2A 3774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.